ghk-cu source SYNTHEX LABS GHK-Cu Copper Peptide

Pen / Pre-mixed Reference Format Pre-mixed vial Concentration 100 mg/mL Dose example 50 mg Volume per dose 0.50 mL (50 units) Format Pre-mixed vial Concentration 100 mg/mL Dose example 100 mg Volume per dose 1.00 mL (100 units) Format Pre-mixed vial (high-conc.) Concentration 200 mg/mL Dose example 100 mg Volume per dose 0.50 mL (50 units) Format Pen device Concentration Set per device Dose example Click-set per dose Volume per dose Per device label Always verify label concentration and pharmacy beyond-use dating

5-amino-1MQ did not inhibit SIRT1 concentrations ranging from 10 nM-300 M, and minor reduction in SIRT1 activity was observed with 600 M 5-amino-1MQ

10.1016/S0197-0186(01)00122-X Neurochem

Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide